A detailed history of Innovis Asset Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Innovis Asset Management LLC holds 73,264 shares of MRK stock, worth $8.21 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares
73,264
Previous 73,233 0.04%
Holding current value
$8.21 Million
Previous $8.45 Billion 10.74%
% of portfolio
2.91%
Previous 3.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$102.95 - $114.33 $3,191 - $3,544
31 Added 0.04%
73,264 $7.54 Billion
Q2 2023

Aug 03, 2023

BUY
$108.61 - $118.38 $1.89 Million - $2.06 Million
17,377 Added 31.11%
73,233 $8.45 Billion
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $526,435 - $587,394
5,114 Added 10.08%
55,856 $5.94 Billion
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $4.44 Million - $5.69 Million
50,742 New
50,742 $5.63 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.